A Systematic Review and Network Meta-Analysis to Assess the Relative Efficacy of Antipsychotics for the Treatment of Positive and Negative Symptoms in Early-Onset Schizophrenia

CNS Drugs
Rebecca C HarveyGemma E Shields

Abstract

Early-onset schizophrenia (EOS) is a serious debilitating disorder with considerable morbidity and a reduced life expectancy; therefore, early diagnosis and effective treatments are particularly important. Negative symptoms are more prominent in adolescents and children (compared with adults), and are key predictors of worse functional and clinical outcomes in EOS. Therefore, this study aimed to explore the relative efficacy of antipsychotics used in the treatment of EOS, with a focus on studies reporting effectiveness using the Positive and Negative Syndrome scale (PANSS), a scale that includes an overall symptom measure, in addition to separate subscales for positive and, importantly, negative symptoms. A systematic literature review was conducted using the MEDLINE and Cochrane Central Register of Controlled Trials databases to identify trials conducted in children and adolescents with schizophrenia, and symptom control was reported using the PANSS. A Bayesian random-effects network meta-analysis was performed, synthesising data for a number of outcomes, including mean change from baseline in PANSS scores, treatment discontinuation and weight gain. Eleven studies were included in the evidence synthesis, comprising 1714 patien...Continue Reading

References

Jul 1, 1991·Schizophrenia Research·J Addington, D Addington
Jul 1, 1990·Archives of General Psychiatry·N C AndreasenS Arndt
May 1, 1987·Journal of the American Academy of Child and Adolescent Psychiatry·L Burd, J Kerbeshian
Jan 1, 1987·Schizophrenia Bulletin·S R KayL A Opler
Sep 1, 1996·Acta Psychiatrica Scandinavica·P H Thomsen
Mar 29, 2003·Psychiatric Services : a Journal of the American Psychiatric Association·David B AllisonDiana D McDonnell
Oct 3, 2003·Journal of General Internal Medicine·Michael B RothbergDavid N Rose
Oct 29, 2005·Schizophrenia Bulletin·Jack J Blanchard, Alex S Cohen
Sep 9, 2006·Journal of Child and Adolescent Psychopharmacology·Tamar MozesAbraham Weizman
Sep 27, 2007·European Child & Adolescent Psychiatry·Nora S VyasSophia Frangou
Dec 6, 2008·Journal of the American Academy of Child and Adolescent Psychiatry·Ludmila KryzhanovskayaMauricio Tohen
Feb 3, 2009·The British Journal of Psychiatry : the Journal of Mental Science·Magali HaasVivek Kusumakar
Oct 8, 2009·International Clinical Psychopharmacology·Harith S SwadiCandace M Bobier
Dec 4, 2009·Schizophrenia Bulletin·Robert W BuchananUNKNOWN Schizophrenia Patient Outcomes Research Team (PORT)
Dec 29, 2009·Journal of Child and Adolescent Psychopharmacology·Magali HaasStuart F Kushner
May 27, 2010·Current Opinion in Psychiatry·Anand K MattaiRhoshel K Lenroot
Aug 27, 2010·Journal of Child Psychology and Psychiatry, and Allied Disciplines·Anthony JamesMichael Goldacre
Jan 29, 2011·The Journal of Clinical Psychiatry·Christoph U Correll
Aug 8, 2012·Archives of General Psychiatry·Mark OlfsonChristoph U Correll
Sep 21, 2012·BMC Psychiatry·Lars ClemmensenHans-Christoph Steinhausen
Oct 23, 2012·Journal of Child and Adolescent Psychopharmacology·Robert L FindlingSanjeev Pathak
Oct 30, 2012·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Sofia DiasNicky J Welton
Jan 22, 2013·BMJ : British Medical Journal·Megan R StaffordTim Kendall
Jan 25, 2013·BMJ : British Medical Journal·Tim KendallUNKNOWN Guideline Development Group
Jun 28, 2013·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Sofia DiasA E Ades
Aug 21, 2013·Child and Adolescent Psychiatry and Mental Health·Gloria M ReevesMark A Riddle
Aug 27, 2013·Journal of the American Academy of Child and Adolescent Psychiatry·Jon McClellanUNKNOWN American Academy of Child and Adolescent Psychiatry (AACAP) Committee on Quality Issues (CQI)
Oct 12, 2013·Journal of Child and Adolescent Psychopharmacology·Robert L FindlingMelissa P DelBello
Oct 17, 2013·The Cochrane Database of Systematic Reviews·Ajit KumarPaul S Russell
Nov 8, 2014·Harvard Review of Psychiatry·Ayşegül YildizRoss J Baldessarini
Jan 1, 2015·NPJ Schizophrenia·Covadonga M Díaz-CanejaCelso Arango

❮ Previous
Next ❯

Citations

Jul 5, 2016·Current Treatment Options in Psychiatry·Gary RemingtonMargaret Hahn
Jan 30, 2018·Journal of Child and Adolescent Psychopharmacology·Ryan S SultanMark Olfson
Jan 23, 2018·Journal of Child and Adolescent Psychopharmacology·Lei XiaXiang-Yang Zhang
Aug 5, 2017·Drugs·Selene R T VeermanLieuwe de Haan
Jan 30, 2020·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·D V IvashchenkoD A Sychev
Apr 4, 2020·Nordic Journal of Psychiatry·Jill BjarkeRolf Gjestad
Apr 28, 2020·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Peiyan Ni, Sangmi Chung
Apr 11, 2019·Journal of Molecular Neuroscience : MN·Katarzyna BogusRyszard Wiaderkiewicz
Sep 25, 2017·Journal of Medical Case Reports·Amna MalikWafaa Eyaid
Feb 8, 2019·European Journal of Clinical Pharmacology·Daria PutignanoMaurizio Bonati
Aug 1, 2018·Journal of Cognitive Psychotherapy·Monica F Tomlinson, Joshua D Wright
Feb 26, 2020·European Psychiatry : the Journal of the Association of European Psychiatrists·Charlotte A ChunLauren M Ellman
Apr 4, 2020·The British Journal of Clinical Psychology·Isabelle ButcherGillian Haddock
Sep 9, 2019·Journal of Psychiatric Research·Ibtihal IbrahimHader Mansour
Jan 31, 2021·Behavioural Brain Research·Daria A ChestnykhChristian P Müller
Oct 2, 2020·Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi·Yuichi OnishiHideo Matsumoto
Apr 25, 2018·Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie·Micha WernerChristian Fleischhaker
Jun 5, 2021·Medicine·Chun-Hung ChangHsin-Chi Tsai
Jul 13, 2021·Clinical Practice and Epidemiology in Mental Health : CP & EMH·Antonio RampinoSilvia Torretta
Aug 28, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Huqun LiCuilian Guo
Mar 1, 2018·Biological Psychiatry : Cognitive Neuroscience and Neuroimaging·James A WaltzJames M Gold
Nov 16, 2021·Frontiers in Psychiatry·Qiaoling SunXiaoping Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here